{"id":"W2070826508","doi":"10.1158/0008-5472.sabcs-4116","title":"Safety of bevacizumab (BV) plus docetaxel (D) in patients (pts) with locally recurrent (LR) or metastatic breast cancer (mBC) who developed brain metastases during the AVADO phase III study.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital du Saint-Sacrement","funders":"","keywords":"Medicine; Metastatic breast cancer; Bevacizumab; Internal medicine; Clinical endpoint; Hazard ratio; Docetaxel; Population; Neutropenia; Taxane; Placebo; Breast cancer; Oncology; Cancer; Surgery; Chemotherapy; Clinical trial; Confidence interval; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001099508,0.0003478607,0.0008857755,0.0004395319,0.0002626563,0.00003430527,0.0003612442,0.0000543651,0.00183142],"category_scores_gemma":[0.00009002518,0.0002002833,0.00008651935,0.001588584,0.0003443316,0.00016196,0.0001250321,0.0007114791,0.000008074273],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00206095,"about_ca_system_score_gemma":0.002482161,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003410601,"about_ca_topic_score_gemma":0.01032333,"domain_scores_codex":[0.9959379,0.0006591351,0.0006874705,0.0006241408,0.001236961,0.0008544272],"domain_scores_gemma":[0.9980178,0.0003218084,0.0001888164,0.0004749651,0.0007300354,0.0002665033],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.4448766,0.02275327,0.0724048,0.001316338,0.004242432,0.00132452,0.01665458,0.0008746303,0.004974432,0.00007225705,0.01444805,0.4160581],"study_design_scores_gemma":[0.3173761,0.02109848,0.6364393,0.002339979,0.001363869,0.000103643,0.003719601,0.0002776128,0.009040631,0.0000424171,0.007333325,0.0008649962],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9887038,0.001885758,0.00001540579,0.004641645,0.0001238506,0.003947838,0.0004697125,0.00002493881,0.0001870844],"genre_scores_gemma":[0.9953123,0.00116328,0.00005086605,0.0003332471,0.0001311613,0.0008658696,0.00004874891,0.00004060148,0.002053929],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5640345,"threshold_uncertainty_score":0.999081,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08245026851302782,"score_gpt":0.450173094100438,"score_spread":0.3677228255874102,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}